Short-term Spinal Stimulation Effects in Cerebral Palsy
Key facts
- Where
- Seattle, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 4 and 65 years old?
Source: NCT07826494, who can take part
Where in United States
- University of WashingtonSeattle, United StatesContact: Katie Landwehr, MSTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Washington
- Trial code
- NCT07826494
- Record updated
- 17 September 2026
- Original description
This research study will examine the acute effects of non-invasive spinal stimulation on spasticity and walking in individuals with cerebral palsy. The hypothesis is that walking with spinal stimulation will lead to greater reductions in spasticity than walking without spinal stimulation. Additionally, it is hypothesized that the average step length and Gait Deviation Index will be higher while walking with spinal stimulation compared to walking without spinal stimulation.Read full original descriptionShow less
Acute Effects of Transcutaneous Spinal Stimulation on Spasticity and Gait in Cerebral Palsy
This research study will examine the acute effects of non-invasive spinal stimulation on spasticity and walking in individuals with cerebral palsy. The hypothesis is that walking with spinal stimulation will lead to greater reductions in spasticity than walking without spinal stimulation. Additionally, it is hypothesized that the average step length and Gait Deviation Index will be higher while walking with spinal stimulation compared to walking without spinal stimulation.
Inclusion: Individuals who:; have a diagnosis of spastic cerebral palsy or high likelihood of CP diagnosis; are 4-65 years of age; have spasticity in lower-extremity muscles; are at a functional Gross Motor Function Classification System (GMFCS) Level I-III; can walk for at least 10 minutes with/without support; can understand and follow simple directions; have a stable medical condition, as reported by the caregiver/parent.
Exclusion: who have had lower-extremity surgery or injury in the prior 12 months; have had botulinum toxin injections in the prior 3 months; have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump); have established osteoporosis and taking medication for osteoporosis treatment; have received stem cell injections into the spinal cord; have uncontrolled seizures; have significant cardiovascular or musculoskeletal disease that would prevent full participation; have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.); have active cancer; Individuals who:; have had selective dorsal rhizotomy (SDR) in the past; are dependent on ventilation support.